Close
Nordic 9Nordic 9

CPH Banque (investor - Bank)

France
See something wrong or missing? Let us know
Offices:Tournai

CPH Banque is a bank from France in Normandie

Average round investment:28.26M USD
Average number per year:1.5
Distribution: 2025 (1)2022 (2)
Portfolio companies: Belgium I-care GroupBelgium Intressa Vascular
Mostly invests in: Belgium Belgium (3) Manufacturing (2)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

CPH Banque mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to CPH Banque

Name Criteria
Belgium Quest for Growth
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States New Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Belgium UCB Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland BioMedPartners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Singapore SPRIM Global Investments
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Isomer Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Merieux Equity Partners
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Charcot-Marie-Tooth Research Foundation
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Trill Impact
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top